Previous close | 0.0700 |
Open | 0.0200 |
Bid | 0.0900 |
Ask | 0.5400 |
Strike | 250.00 |
Expiry date | 2025-01-17 |
Day's range | 0.0200 - 0.0700 |
Contract range | N/A |
Volume | |
Open interest | 95 |
AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Landos Biopharma, Inc. (NASDAQ: LABP). With the completion of the acquisition, Landos is now part of AbbVie.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.